Jeannie Woith Discusses the Benefits of Low-Level Laser Therapy for Oral Mucositis

Article

Jeannie Woith, BSN, RN, LMT, The James Cancer Hospital, The Ohio State University, discusses the benefits of treating oral mucositis with low-level laser therapy.

Jeannie Woith, BSN, RN, LMT, The James Cancer Hospital, The Ohio State University, discusses the benefits of treating oral mucositis with low-level laser therapy.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a woman with blonde hair wearing a denim jacket in front of a blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Related Content
Graphic reading "FDA Approved" resembling a stamp of approval

FDA Approves 2 Indications for Penpulimab-kcqx in Non-Keratinizing NPC

Bridget Hoyt
April 24th 2025
Article

The FDA approved penpulimab-kcqx combination and monotherapy for non-keratinizing nasopharyngeal carcinoma.

Shawna Douglas On How Nurse Navigators Help Ease the Treatment Burden for Patients With Head and Neck Cancer

Shawna Douglas On How Nurse Navigators Help Ease the Treatment Burden for Patients With Head and Neck Cancer

Lindsay Fischer
September 1st 2023
Podcast

Shawna Douglas, BSN, RN, discusses the role that nurse navigators play in caring for patients with head and neck cancer.

Image of an IV tube in focus, with a nurse in the background holding the tube

Neoadjuvant Pembrolizumab Gets FDA Priority Review in Resectable HNSCC

Courtney Flaherty
March 2nd 2025
Article
White line illustration of the head and neck, including the nasal cavity and throat, on a cornflower blue background

Petosemtamab/Pembrolizumab Receives FDA Breakthrough Designation for PD-L1+ HNSCC

Chris Ryan
February 28th 2025
Article

The FDA granted petosemtamab plus pembrolizumab breakthrough therapy status for PD-L1–positive recurrent/metastatic head and neck squamous cell carcinoma.

Simple line illustration of a thyroid against a dark blue background

Thyroidectomy Without Radioiodine May Be Noninferior to Radioiodine Use in Thyroid Cancer

Roman Fabbricatore
February 6th 2025
Article

More excellent responses occurred for patients with low-risk thyroid cancer who had thyroidectomies without radioiodine vs treatment with radioiodine.

green background with FDA in blue text and approved with a checkmark in darker green text

FDA OKs Subcutaneous Nivolumab in Advanced/Metastatic Solid Tumors

Chris Ryan
December 27th 2024
Article

Nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) was approved by the FDA for subcutaneous injection across approved solid tumor indications for nivolumab (Opdivo).